- Investigator
- James Wymer
- Status
- Accepting Candidates
Research at a glance
Top areas of exploration
- Amyotrophic Lateral Sclerosis , 28 publications
- Deglutition Disorders , 10 publications
- Deglutition , 9 publications
- Disease Progression , 5 publications
Research activity
Active clinical trials
The purpose of this study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of NMD670 in the treatment of ambulatory adults with spinal muscular atrophy type 3
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the treatment of ALS.
- Investigator
- James Wymer
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
My publications
Filter publications
47 publications
2023
Respiratory Strength Training in Amyotrophic Lateral Sclerosis
Neurology
Publisher's site2023
Respiratory therapies for Amyotrophic Lateral Sclerosis: A state of the art review.
Chronic respiratory disease
PubMed • Publisher's site2023
Sensitivity and specificity of the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised to detect dysarthria in individuals with amyotrophic lateral sclerosis.
Muscle & nerve
PubMed • Publisher's site2023
Temporal serum metabolomic and lipidomic analyses distinguish patients with access-related hand disability following arteriovenous fistula creation.
Scientific reports
PubMed • Publisher's site2023
The natural history of ALS: Baseline characteristics from a multicenter clinical cohort
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Publisher's site